Kinase inhibitors as drugs for chronic inflammatory and imm

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » Expert Opinion's
Reply to topic
Kinase inhibitors as drugs for chronic inflammatory and imm
RSS FEED


Joined: 05 Apr 2006
Posts: 19275
Post Posted: Mon Jun 23, 2008 1:32 pm Reply with quote


Expert Opinion on Therapeutic Targets , July 2008, Vol. 12, No. 7, Pages 883-903.
<br/>
At the time of writing, there are seven marketed kinase inhibitor drugs. The first kinase inhibitor, imatinib mesilate (Gleevec®, Novartis), came to market in 2001, an inhibitor of the breakpoint cluster region (BCR)/Abelson murine leukemia oncogene ...

Read more...

Source: Expert Opinion: Expert Opinion on Therapeutic Targets: Table of Contents
Table of Contents for Expert Opinion on Therapeutic Targets. List of articles from both the latest and ahead of print issues.
View user's profileSend private message
Kinase inhibitors as drugs for chronic inflammatory and imm
All times are GMT - 7 Hours  
Page 1 of 1  
  
  
Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » Expert Opinion's
 Reply to topic  
Forum Map
Site Map